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knowledge about underlying patholo-
gies.[2] The aim of liver tissue engineering 
is to develop three-dimensional (3D) liver 
tissues that replicate the in vivo liver func-
tions as close as possible.[3] Successful 
liver constructs can on one hand side 
serve as a testing platform for xenobiotics, 
toxins, or as disease models.[4] On the 
other side, they can be used in vivo as an 
alternative for donor organs and as a basis 
for stimulating liver regeneration through 
cell delivery.[4]
Considering that one of the most sig-
nificant causes for an acute liver failure 
(ALF) are drug-induced liver injuries (11% 
of all ALF cases in the United States),[5] 
there is a clear need for preclinical drug 
testing models that can accurately pre-
dict the effect of drugs on the liver tissue 
and improve the success rate of only 10% 
in clinical drug testing.[6] Current tissue-
engineered liver models have significant 
disadvantages that hamper their use. Pres-
ently, the gold standard to test toxicity and metabolism consists 
of primary human hepatocyte cultures in 2D. However, 2D cul-
tures fail to represent the complex 3D structure of native liver 
tissue[7] and further problems associated with primary hepato-
cytes are limited availability, restricted lifespan, rapid dediffer-
entiation, functional variability, and a limit in drug transporter 
To replicate functional liver tissue in vitro for drug testing or transplantation, 
3D tissue engineering requires representative cell models as well as scaffolds 
that not only promote tissue production but also are applicable in a clinical 
setting. Recently, adult liver-derived liver organoids are found to be of much 
interest due to their genetic stability, expansion potential, and ability to dif-
ferentiate toward a hepatocyte-like fate. The current standard for culturing 
these organoids is a basement membrane hydrogel like Matrigel (MG), which 
is derived from murine tumor material and apart from its variability and high 
costs, possesses an undefined composition and is therefore not clinically 
applicable. Here, a cellulose nanofibril (CNF) hydrogel is investigated with 
regard to its potential to serve as an alternative clinical grade scaffold to 
differentiate liver organoids. The results show that its mechanical properties 
are suitable for differentiation with overall, either equal or improved, func-
tionality of the hepatocyte-like cells compared to MG. Therefore, and because 
of its defined and tunable chemical definition, the CNF hydrogel presents 
a viable alternative to MG for liver tissue engineering with the option for 
clinical use.
1. Introduction
Liver diseases were the 12th leading cause of death in the 
United States in 2015 and the numbers are increasing.[1] Rea-
sons for this high mortality include a lack of good treatments, 
a shortage of donor livers for transplantation, and a lack of 
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activity.[8] Moreover, despite their large replication capacity in 
vivo, hepatocytes cannot be expanded in culture.[9] A predictive 
cell model, therefore, needs to have a stable hepatic signature 
and the potential to expand to be readily available,[9] and should 
be 3D.[8] For stem cell derived hepatocyte like cells or even 
adult hepatocytes, it is known that a 3D structure leads to an 
improved survival rate and functional phenotype.[10]
One of the potential solutions is using liver-derived adult 
stem cells cultured as organoids. These organoids create 
structures that resemble their organ of origin by assembling 
themselves into a 3D structure and growing and expanding in 
vitro.[11] Adult stem cells isolated from human liver biopsies 
can be cultured in a 3D extracellular matrix (ECM) mimicking 
the microenvironment of these cells in vivo.[11] Liver organoids 
allow for an almost infinite and genetically stable expansion of 
adult stem cells in vitro and can be differentiated into hepat-
ocyte-like cells.[9] These organoids are maintained in Matrigel 
(MG), which is a thermosensitive hydrogel prepared from a 
basement membrane rich sarcoma, the Engelbreth−Holm−
Swarm murine tumor, which must be propagated in mice.[12] 
Therefore, MG is a material of undefined murine origin with 
a high batch-to-batch variability of up to 50%[13] and high pur-
chase costs.[12] For the liver organoids to be used in in vitro 
models or in the clinic, new hydrogels need to be tested that 
allow for a better hepatic differentiation, and provide a scaffold 
that can be applied clinically. For clinical application, it is essen-
tial for the material to have the potential for approval by the 
FDA or other regulatory bodies and comply with good manu-
facturing practices, which is not possible for MG, due to the 
animal origin and undefined composition.[3]
One potential alternative biomaterial for MG that is shear 
thinning, swellable in water, and enables 3D cell culture is cel-
lulose, which is the most abundant biopolymer on earth with 
its main source being cell walls of plants.[14,15] In nature, cel-
lulose is formed by micron-sized fibril agglomerations of 
diameters between 2 and 20 µm, depending on its source.[16] 
Extraction can be achieved through oxidation mediated by 
2,2,6,6-tetramethylpiperidinyl-1-oxyl (TEMPO), which catalyzes 
the oxidation of primary alcohol groups in the presence of 
water.[16] In this way, aldehyde and carboxyl groups are intro-
duced[17] on to the surface of the fibers[16] resulting in a nega-
tive surface charge which enables the subsequent separation 
of the fibrils[17] with a pressure homogenizer.[18] This results in 
nanofibrils with a thickness of 2.5 ± 2 nm that are very crystal-
line and have a high aspect ratio.[18] These fibrils, consisting of 
β-d glycopyranose polysaccharide chains[6] are one of the stiffest 
natural biomaterials with Ecellulose.I = 138 GPa and they are the 
underlying reason for the remarkable mechanical properties 
of the hydrogel.[18] When mixed with water, they form revers-
ible cellulose nanofibril (CNF)[17] hydrogels already at very low 
solid contents[18] of ≈0.2%. The nanoscale network within this 
hydrogel can be seen in SEM images of the material.[19] The 
shear-thinning and self-healing behavior associated with this 
hydrogel[18] is due to the entanglement, hydrogen bonds, and 
ionic interactions that keep it together,[17] which also prevent 
degradation in aqueous environments.[20] The CNF is naturally 
biocompatible[12,21] and has therefore been used for different 
tissue engineering applications. Among those with promising 
results are cultures in CNF hydrogel of stem cells,[12] culture,[6] 
and differentiation[8] of liver cell lines such as HepaRG and 
HepG2 or progenitor cell thereof and as a sacrificial template 
for the engineering of tubular cell constructs.[19] The hydrogel 
is very stable in the long term and fabrication costs are much 
lower compared to other materials, such as MG.[20] CNFs are 
not degradable in humans,[14,22,23] but controlled degradation 
can be achieved by either adding the enzyme cellulase[12,22] or 
making use of the shear-thinning properties and reaching deg-
radation through medium flow[24] if desired.
To our knowledge CNF hydrogels have only been tested 
in combination with cell lines, which are associated with the 
abovementioned drawbacks. Cellulose as a natural polymer 
in combination with human liver organoids would fulfil most 
of the significant characteristics necessary for successful liver 
tissue engineering mentioned in a recent review on the specific 
demands of hydrogels for this purpose.[3] These are namely the 
human autologous cell source, the potential to include vascula-
ture, possible additions of bioactive substrates, biocompatibility, 
bioprintability, chemical definition, mechanical properties in 
the range of 0.2−1 kPa and the possibility to be degradable. 
Therefore, the aim of this study is to test the potential of CNF 
hydrogels as a scaffold for liver tissue engineering. For that 
purpose, human liver organoids from several donors were 
differentiated in CNF hydrogels and examined with respect 
to their metabolic activity, maturation level, functionality, and 
polarization in comparison to MG to assess the potential of 
CNF as a scaffold for differentiation of human liver organoids 




To examine the mechanical characteristics of the hydrogel, 
we have performed a rheological analysis by conducting an 
amplitude sweep measurement (Figure 1A), frequency sweep 
(Figure 1B), altering strain measurement (Figure 1C), and 
dynamic viscosity measurement (Figure 1D). As is visualized 
in Figure 1A, CNF hydrogel exhibits highly elastic behavior 
with G′ (84.1 ± 4.2 Pa) roughly 10 times that of G″ (8 ± 0.4 Pa) 
before the critical strain point of about 100% strain. From the 
frequency sweep in Figure 1B, it can be observed that G′ and 
G″ are nearly constant over the range of frequencies between 
0.1 and 10 rad s−1 with G′ > G″. Rapid self-healing is demon-
strated by the altering strain experiment shown in Figure 1C. 
At high strains G″ is higher than G′, but by altering back to low 
strain, the storage modulus G′ recovers quickly, restoring the 
original viscoelastic property. Complete recyclability is shown 
by repeating this process over five cycles without a change in 
property. The CNF hydrogel also demonstrates shear-thinning 
behavior as can be seen in Figure 1D with a viscosity decrease 
for increasing shear rates. The Young’s modulus (E) is calcu-
lated to be ≈255 Pa with a plateau value of G′ of 85 Pa of the 
frequency sweep.
As can be seen in Figure 2, the swelling ratio of the CNF 
hydrogel in demineralized water increases by 17% (±7.5) after only 
30 min, which reduces the cellulose concentration from 0.6% (w/v) 
Adv. Healthcare Mater. 2020, 9, 1901658
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to 0.54% (w/v) (±0.04) and there is no equilibrium reached after 
4 h. This is also the reason for the high standard deviations, as dif-
ferentiation between the hydrogel and water is hardly possible after 
extended swelling times. This effect is not observed for swelling in 
phosphate buffered saline (PBS), where an equilibrium is reached 
after only 30 min.
2.2. . Morphology and Metabolic Activity
To test the potential of human liver organoids to expand within 
the CNF hydrogel, the organoids were reseeded into MG and CNF 
hydrogels and cultured for 7 days with expansion medium (EM). 
The Alamar Blue staining (Figure S1, Supporting Information) 
shows that there is no significant increase in metabolic activity 
over the culture period within the CNF hydrogel, whereas the 
metabolic activity increases by 73% (p = 0.0011) in MG, which 
indicated that organoids cannot be propagated in CNF.
For assessing the differentiation potential, human liver orga-
noids from three donors were expanded in MG before being 
transferred to another MG or to CNF. In MG, two different 
media conditions were compared—EM and differentiation 
medium (DM). In CNF hydrogel, only DM was used to show 
the differentiation potential of the biomaterial. In Figure S2, 
Supporting Information, it is shown that the metabolic activity 
within each day is not significantly different between any of the 
CNF hydrogel concentrations, therefore the data were averaged 
over all donors and CNF hydrogel concentrations and represent-
ative images are shown for morphology. When comparing CNF 
hydrogels to MG, more condensed, smaller, and darker human 
liver organoids were observed (Figure 3A). In the case of DM, 
the organoids did not appear to be proliferating in both MG and 
CNF hydrogel, while control samples cultured in MG with EM 
continued to grow over these 7 days. This was confirmed by the 
Alamar Blue staining, indicating that the total metabolic activity 
increases over time for organoids cultured in MG in EM up to 
120% (p = 0.0011) on day 7 (Figure 3B). The organoids in MG 
and DM show no significant change in metabolic activity. In CNF 
hydrogel, an initial reduction of metabolic activity was observed 
for all donors with an average decrease of 23% (p < 0.0001) from 
days 1 to 4 but no significant difference between days 4 and 7.
2.3. Gene Expression
To determine the maturation level and fate of the hepatocyte-
like cells after differentiation for 7 days in both CNF hydrogel 
Adv. Healthcare Mater. 2020, 9, 1901658
Figure 1. Rheological data of 0.4 mL of 0.6% (w/v) cellulose nanofibril (CNF) hydrogel at 20 and a plate gap of 0.5 mm. A) Dynamic oscillatory ampli-
tude sweep measurement at 1 rad s−1. B) Frequency sweep measurements at 0.5% oscillating strain. C) Altering strain measurement between 1% and 
500% in periods of 30 s. D) Dynamic viscosity measurement with 5 s equilibrium time and 30 s averaging time.
Figure 2. Degree of swelling for 0.5 mL 0.6% (w/v) cellulose nanofibril 
(CNF) hydrogel in 2 mL demineralized water and 1× PBS over 4 h, data 
depicted as mean ± SD (n = 3).
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and MG, expression of genes was tested for DM and EM con-
ditions. In Figure S3, Supporting Information, it is shown that 
gene expression is not statistically different between the great 
majority of the CNF concentrations, therefore the data were 
averaged over all cell donors and CNF conditions. For com-
parison, primary hepatocytes and a liver sample were analyzed 
simultaneously. Overall, expression levels of genes are always 
higher in DM compared to EM conditions, while in some cases 
the CNF hydrogel even outperforms MG. For example, expres-
sion levels of adult phase I specific enzymes, which belong 
to the cytochrome P450 family (CYP3A4, CYP1A2, CYP2D6, 
CYP2C19), demonstrate organoid functionality (Figure 4,). 
From these genes, CYP3A4 is expressed at 59% (p = 0.0373) 
higher levels in CNF DM compared to MG DM. For the phase 
II enzymes, UDP glucuronosyltransferase (UGT) (Figure 4K) 
and sulfotransferase (SULT) (Figure 4J), SULT presents a 32% 
(p = 0.0205) higher level of expression in the case of CNF 
DM over MG DM. Finally, phase III enzymes mitochondrial 
ribosomal protein S2 (MRP2) (Figure 4I) and ATP-binding 
cassette subfamily B member 11 (BSEP) (Figure 4E) both 
show no significant difference between organoids in CNF 
hydrogel or MG in DM. Only the stem cell marker leucine-
rich repeat-containing G-protein coupled receptor 5 (LGR5), is 
expressed at significantly lower levels in both DM conditions 
(MG or CNF) compared to EM. Interestingly, some expression 
of this stem cell marker remained in CNF hydrogels (55%, 
p = 0.0117), while no expression was observed in MG with DM 
(Figure 4H).
2.4. Transaminase Activity
To further evaluate the performance of CNF hydrogels for dif-
ferentiation of human liver organoid cultures in comparison to 
MG, the functionality of the hepatocyte-like cells was investi-
gated by measuring the transaminase activity. For this purpose, 
cells were collected after 7 days of culture, where organoids in 
CNF hydrogels were differentiated with DM, whereas orga-
noids in MG were cultured in both EM and DM, respectively. 
No significant differences between any CNF hydrogel con-
centrations (Figure S4, Supporting Information) results were 
observed and therefore data were averaged over donors and gel 
concentrations. Multiple hepatic markers were significantly 
higher in organoids under CNF DM conditions compared to 
MG DM conditions, such as alanine aminotransferase (ALAT) 
(28%, p < 0.0001) (Figure 5), aspartate transaminase (ASAT) 
(22%, p = 0.009), albumin production (85%, p < 0.0001), 
and glutamate dehydrogenase (GLDH) production (14%, 
p = 0.0459). Interestingly, ALAT enzyme, albumin, and GLDH 
production is not significantly different in MG when DM or 
EM is used. In contrast, organoids cultured in CNF hydrogel 
demonstrated higher levels of these differentiation signals 
compared to MG.
2.5. Immunocytology
For visualization and determination of specific expression sites, 
sections of the human liver organoids from all donors cul-
tured in CNF hydrogel in DM or MG in DM or EM for 7 days, 
were stained immunocytochemically. Antibodies against the 
differentiation markers albumin, HNF4a, MRP2, tight junc-
tion protein, and polarization marker ZO1, as well as for gly-
cogen accumulation with the Periodic acid−Schiff (PAS) stain 
were applied (Figure 6). The increase in albumin RNA levels 
in CNF hydrogels was confirmed by immunocytochemistry 
(Figure 6C), especially when compared to MG EM condi-
tions (Figure 6A). The localization of albumin in MG is on 
the luminal side (Figure 6B), whereas it is on the apical side 
of the organoid in CNF. The early hepatocyte specification 
marker HNF4a is a transcription factor in the nuclei of orga-
noids, therefore every staining outside the nuclei is unspecific. 
The specific nuclear staining can only be observed in CNF DM 
(Figure 6F) conditions, in MG EM and DM it is unspecific 
(Figure 6D,E). Another marker is MRP2, a protein expressed in 
the canalicular apical part of a hepatocyte that functions in bil-
iary transport and therefore equally serves as a differentiation 
Adv. Healthcare Mater. 2020, 9, 1901658
Figure 3. A) Representative brightfield images showing liver organoid 
morphology on days 1 and 7 after transfer into Matrigel (MG) under 
expansion medium (EM) or differentiation medium (DM) conditions, or 
in cellulose nanofibril (CNF) hydrogel 0.4% (w/v) under DM conditions, 
scale bar 500 µm. B) Metabolic activity at days 4, 6, and 7 relative to 
values at day 1 (n = 9 for MG EM and DM, n = 24 for CNF DM); data 
depicted as box with median and 25th and 75th percentile and whiskers 
from min to max (**p < 0.01, ****p < 0.0001, ns: not significant), ANOVA 
with Tukey’s post-hoc test.
www.advancedsciencenews.com www.advhealthmat.de
1901658 (5 of 12) © 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
and polarization marker.[25] It is clearly visible that MRP2 stains 
more positive in the apical membrane of the organoids in CNF 
hydrogel and accumulates more toward the luminal side of 
the organoid (Figure 6I), whereas the staining is more posi-
tive toward the basal part of the organoid for MG (Figure 6H). 
The staining in EM condition is negative. Similarly, the tight 
junction protein ZO1 should be located toward the end of the 
lateral membrane in proximity to the bile cuniculi, indicating 
the polarity of hepatocytes.[25] It is observed in Figure 6L  
that the staining for ZO1 in CNF hydrogel is clearly located 
along the plasma membrane with a preference for the basal side 
of the organoid, while the staining is less specific for both MG 
conditions (Figure 6J,K). Accumulation of glycogen in the dif-
ferentiated organoids is observed in both CNF hydrogel and 
Adv. Healthcare Mater. 2020, 9, 1901658
Figure 4. Relative gene expression to GAPDH and RPL19 of liver organoids differentiated in Matrigel (MG) and cellulose nanofibril (CNF) hydrogels 
(MG DM, CNF DM) for 7 days or cultured for 7 days in MG with EM (MG EM), with levels of native liver and hepatocytes as controls. Data are aver-
aged over all CNF hydrogel concentrations (0.2−0.6% w/v) and donors. A) Albumin expression (n = 15 for MG EM, n = 15 for MG DM, n = 39 for 
CNF), B) CYP1A2 expression (n = 4 for MG EM, n = 8 for MG DM, n = 21 for CNF), C) CYP2C19 expression (n = 15 for MG EM, n = 15 for MG DM, 
n = 39 for CNF), D) CYP 2D6 expression (n = 15 for MG EM, n = 15 for MG DM, n = 42 for CNF), E) BSEP expression (n = 15 for MG EM, n = 15 for 
MG DM, n = 40 for CNF), F) CYP3A4 expression (n = 15 for MG EM, n = 15 for MG DM, n = 40 for CNF), G) HNF4a expression (n = 15 for MG EM, 
n = 15 for MG DM, n = 41 for CNF), H) LGR5 expression (n = 12 for MG EM, n = 12 for MG DM, n = 33 for CNF), I) MRP2 expression (n = 15 for MG 
EM, n = 15 for MG DM, n = 42 for CNF), J) SULT expression (n = 12 for MG EM, n = 13 for MG DM, n = 29 for CNF), K) UGT expression (n = 15 for 
MG EM, n = 14 for MG DM, n = 35 for CNF). All data depicted as mean ± SD (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns: not significant), 
ANOVA with Tukey's post-hoc test.
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MG (Figure 6N,O) at higher levels compared to EM conditions 
(Figure 6M).
3. Discussion
In this study, we have shown that CNF hydrogels are a viable alter-
native for MG and improve the hepatic differentiation of orga-
noids. In the current configuration, the CNF hydrogel does not 
sustain organoid proliferation (data not shown) but does induce 
hepatic maturation. The positive attributes of CNF hydrogel and 
its potential for organoid differentiation are discussed below.
3.1. CNF Hydrogel Characterization
The relatively high resistance of CNF hydrogel to strain is 
an indicator for constant remodeling of the nanofibril net-
work,[26] even in an atomic force microscopy image of a very 
low CNF concentration (0.005% w/v) it has been shown that 
the nanofibrils are very densely packed and prevent the cells 
from working around the fibers.[18] The self-healing character of 
the gel was demonstrated by the alternating strain experiment. 
The reversible switch of dominance between G′ and G″ at 
high strains show that the CNF hydrogel network broke down 
and flowed like a viscous solution but recovered completely 
Adv. Healthcare Mater. 2020, 9, 1901658
Figure 5. Functional read-out in relative enzyme activity and albumin concentration corrected to the metabolic activity of hepatocyte-like cells lysed after 
7 days of differentiation in cellulose nanofibril (CNF) hydrogel (data averaged over all concentrations) and Matrigel (MG) in differentiation medium 
(DM) (CNF DM (n = 16 for Albumin and GLDH, n = 24 for ALAT and ASAT), MG DM (n = 6 for Albumin and GLDH, n = 9 for ALAT and ASAT)) as 
well as in MG in expansion medium (EM) (MG EM (n = 6 for Albumin and GLDH, n = 9 for ALAT and ASAT)) as comparison. Data are averaged over 
all donors, all data depicted as mean ± SD (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.1, ns: not significant), ANOVA with Tukey’s post-hoc test.
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without any loss of its properties, which shows that there was 
no destruction on the molecular level.[26] The low gradient of G′ 
and G″ in the frequency sweep demonstrated that the gel had 
a strong internal network and is quite structured.[26] Compared 
to CNF hydrogel, MG exhibits similar behavior at lower fre-
quencies but the crossover point of G′ and G″ is already below 
100 rad s−1. [27] For CNF, the storage modulus G′ decreased 
linearly up to 13% strain, which is similar compared to MG, 
but in contrast to the CNF hydrogel, MG has a very low viscous 
response, which is demonstrated by the unmeasurable loss 
modulus G″.[27] In addition, MG does not possess the capability 
to restore its structure after release like CNF hydrogel. The lack 
of self-healing properties are a major reason for the absence 
of successful permanently cross-linked hydrogels in clinical 
settings.[28] Therefore, the CNF hydrogel has an advantage in 
tissue engineering and regenerative medicine due to its unique 
properties, as it is injectable due to its shear-thinning character 
and self-healing after breaking.
The observed swelling of CNF hydrogel in demineral-
ized water is caused by the Higgs−Donnan effect,[29] where 
the deprotonation of the C6 carboxyl group of the hydrogel 
results in water entering into the gel to equalize the difference 
in osmotic pressure. Therefore, the gel will not stop swelling 
until it is completely dissolved in water. Deprotonation is 
not possible in PBS, therefore, no negative charges lead to 
swelling of the gel. This means that CNF hydrogel is stable in 
Adv. Healthcare Mater. 2020, 9, 1901658
Figure 6. Representative immunohistochemical and periodic acid−Schiff (PAS) stainings of human liver organoids cultured in Matrigel (MG) or cel-
lulose nanofibril (CNF), respectively. A) Albumin staining, MG EM, donor h2; B) Albumin staining, MG DM, donor h5; C) Albumin staining, CNF 
0.2, donor h5; D) HNF4a staining, MG EM, donor h2; E) HNF4a staining, MG DM, donor h2; F) HNF4a staining, CNF 0.2, donor h2; G) MRP2 
staining, MG EM, donor h2; H) MRP2 staining, MG DM, donor h2, I) MRP2 staining, CNF 0.6, donor h2; J) ZO1 staining, MG EM, donor h5; K) ZO1 
staining, MG DM, donor h5; L) ZO1 staining, CNF 0.6, donor h5; M) PAS staining, MG EM, donor h5; N) PAS staining, MG DM, donor h2; O) PAS staining, 
MG EM, donor h2. Scale bar: 50 µm.
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salt-containing solutions as medium used for organoid cultures 
but can be swollen and disintegrated into demineralized water.
3.2. Human Liver Organoid Performance
Expansion of human liver organoids in CNF hydrogel is not 
successful, as metabolic activity in the CNF hydrogel does not 
significantly increase over time as opposed to MG. This might 
be caused by the characteristics of the hydrogel, which through 
its mechanical properties, and potentially mismatch in deg-
radation rate, may limit the organoids in proliferation. It has 
been shown that organoid formation and expansion occurs 
in a narrow mechanical window; stiffer gels support expan-
sion (1.3 kPa for intestinal organoids), whereas differentia-
tion requires softer gels (0.2 kPa).[30] However, little is known 
about how the mesh size and degradation rate of the hydrogel 
affects these processes, even though they are highly coupled to 
the mechanical properties. Generally, cells sense the bulk scaf-
fold elasticity, while in viscoelastic materials they can further 
mechanically remodel their surrounding depending on the 
relaxation rate and cell type.[31] In future investigations, the 
mechanical properties of the CNF hydrogel could be adapted 
to suit the application of organoid expansion, and softened 
over time through controlled enzymatic degradation. Addition-
ally, ECM components proven to be advantageous for organoid 
growth, such as laminin-111, collagen IV, and fibronectin, 
could be incorporated.[32]
Morphological appearance and metabolic activity results of 
the human liver organoids in MG in EM and DM conditions 
are consistent with previously shown results.[9] The morphology 
of the organoids in CNF hydrogel appear darker, not as round 
and with a less even surface as compared MG cultures. This is 
due to an inversed polarity of the cells where the apical side of 
the organoid is oriented outwards and presents this more irreg-
ular appearance, as has been previously shown for intestinal 
organoids.[33] This change in polarity was corroborated with 
immunocytology showing polarity-specific proteins and is due 
to the lack of ECM proteins regulating the polarity in the CNF 
hydrogel that are present in MG.[33] Where the ECM compo-
nents are in direct contact with the cells, it creates the basolat-
eral membrane. Especially laminins are believed to cause this 
effect which lead to a cascade of integrin signaling and estab-
lishes polarity.[34]
As opposed to MG, organoids in CNF hydrogel presented a 
decrease in metabolic activity within the first 4 days, which was 
most likely caused by cell death due to the different exposure of 
organoids during initial handling. Because the CNF hydrogel 
coagulates and loses its self-healing characteristic when mixed 
with salt-containing solutions, the organoids extracted from the 
MG, where they were expanded in, were mixed with the CNF 
hydrogel in the presence of demineralized water, while media 
was directly added after plating of the hydrogel. The loss of 
its self-healing characteristics is hypothesized to be caused by 
protonation of the CNF hydrogel’s carboxyl groups by sodium 
cations. Because of the positively charged sodium cations, the 
previously negatively charged carboxyl groups lose their repul-
sive forces, which are required for the materials self-healing 
character through ionic interactions[17] and therefore CNFs 
agglomerates. Thus, the organoids placed in the CNF hydrogel 
needed to adjust to the new environmental conditions, which 
resulted in a reduced viability at the beginning of differentia-
tion. On the other hand, metabolic activity levels prove that the 
cells stabilized and stayed viable over the remaining culture 
period. After an initial acceptable reduction of 23% in meta-
bolic activity, cells regained their stability once culture medium 
was added and diffused into the gel, delivering the necessary 
nutrients for cell survival and function. In a previous report, a 
similar effect was observed, where fibroblasts spheroids inside 
CNF hydrogel first demonstrated a dead outer cell layer upon 
inclusion into the hydrogel to then recover viability in this 
area after a culture period of 2 weeks.[24] This effect could in 
the future be alleviated by introducing other groups, which 
cannot be protonated, onto the surface of the CNFs instead 
of the carboxyl groups. In addition, incorporation of moieties 
that stimulate cell activity and proliferation, as shown in other 
hydrogels,[35] could improve the overall functionality of the 
hepatocyte-like organoids.
Apart from the surrounding medium conditions that influ-
ence the liver organoid cells, another factor is the stiffness of 
the gel. As MG and 0.6% (w/v) CNF hydrogel are soft hydrogels 
according to their Young’s moduli (≈255 Pa for CNF hydrogel 
and +440 Pa for MG [36]), there is no great difference on the 
macroscale. It is known that the ECM close to hepatocytes is 
soft (E ≈ 1.5 kPa)[37] and that soft surfaces promote hepatic stem 
cells to differentiate into hepatocytes.[38] On the other hand, soft 
matrices have also proven to be beneficial for intestinal orga-
noid differentiation.[30] Importantly, despite the low Young’s 
modulus, CNF hydrogel is composed of very stiff nanofibrils 
(E = 138 GPa),[18,19] providing mechanical cues on the nanoscale 
that can influence cell differentiation and performance.[37] The 
hepatic organoids in CNF hydrogel appeared much darker 
and differently shaped compared to MG, which could be due 
to collapse and folding caused by mechanical forces and/or 
the lack of growth factors, laminin, and adhesion sites in the 
CNF hydrogel. However, this difference in appearance did not 
have a negative effect on the performance of the differentiated 
organoids. Remarkably, liver organoids were still able to form 
in the CNF hydrogel and fuse together into larger constructs, 
although the gel is not degradable without the addition of the 
enzyme cellulase.[14,22,23] This indicates that the environment 
can adapt to the organoid structures and is beneficial for the 
cells.
The functionality of the hepatocyte-like cells in CNF hydrogel 
was on average higher when the different read-outs were com-
pared. The organoids in the CNF hydrogel were metabolically 
active and produced higher levels of enzymes (ALAT, ASAT, 
GLDH, albumin) compared to MG. Overall, differentiation 
in CNF hydrogels seemed to have occurred at a higher level 
compared to MG, which is also indicated by the significantly 
higher levels of albumin production compared to both MG DM 
and MG EM. However, this observation is not confirmed by 
the gene expression analysis, which shows that albumin was 
expressed at similar levels in either hydrogel in DM condition, 
but significantly higher than in the EM condition. In addition, 
immunostaining presented a similar expression of albumin, 
albeit oppositely located in the organoid. Even though some 
conflicting results may be caused by the large variability in data 
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in the case of albumin enzyme activity among all functional 
read-outs, it can still be concluded that all analysis methods 
reveal that albumin production is at least as high in the CNF 
hydrogel as in MG. In contrast, the differentiation marker 
LGR5 did show higher expression levels in CNF hydrogel com-
pared to MG, which indicates that more stem cells were still 
present in CNF after differentiation. On the other hand, even 
though the marker for hepatocyte fate, HNF4a, did not show a 
significant difference in gene expression, the immunostaining 
demonstrated more specific nuclear staining in the case of CNF 
hydrogel as opposed to MG, indicating that indeed the cells 
developed into functional hepatocytes. This finding is empha-
sized by the expression levels of the enzymes that are involved 
in the metabolism of xenobiotics (phase I to III), which show 
that the CNF hydrogel performed at least equally as well as 
the gold standard of MG and was even superior in two cases 
(CYP3A4 and SULT). In all tested genes except for CYP1A2, 
which did not display any differences, expression levels showed 
successful differentiation, as they were consistently higher than 
levels in organoids remaining in EM. Results are comparable 
to other organoid studies in MG and poly(ethylene glycol) 
hydrogels,[9,35,39] as well as with cell lines (HepaRG progenitor 
cells) in nanofibrillar cellulose and hyaluronan-gelatin (HG) 
hydrogels.[8]
Although the expression of the hepatic markers was higher 
in the CNF conditions compared to MG, the overall expression 
of these genes in native hepatocytes and liver samples were still 
higher. This shows that the liver organoids still did not fully 
reach the same maturity. It is known that several other factors 
in the microenvironment are needed to improve this hepatic 
maturation, including co-culture, smaller microgels produced 
with microfluidics, amongst others.[40] Interestingly, both the 
polarization markers MRP2 and ZO1, which are located at the 
apical membrane of a native hepatocyte and at the apical mem-
brane or in close proximity thereof, respectively,[25,41] showed 
a different localization in organoids cultured in CNF hydrogel 
compared to MG. Polarization of cells is induced by the ECM 
in livers or by ECM mimicking materials in vitro and is very 
important for the function of the cells.[3] The needed apicobasal 
polarity can be found in both CNF hydrogel and MG, however, 
it was more pronounced in CNF but polarity was inversed. In 
the CNF hydrogel, the basal membrane of the hepatocytes was 
facing away from the lumen, which presents advantages for tox-
icity and drug uptake testing, because the compounds would 
not have to be included inside the organoids but can be admin-
istered with the medium from the outside. The MRP2 and ZO1 
staining further indicate the formation of bile canaliculi-like 
structures, another hallmark for the structure of liver tissue.
An extensive review on hydrogels for liver tissue engineering 
has been published recently, naming many advantages and dis-
advantages of multiple natural and synthetic hydrogels with 
respect to the specific demands for liver tissue engineering.[3] 
Biocompatible CNF hydrogel specifically fulfils some of these 
requirements as it has the ability to culture autologous cell 
sources, as also proven in this study.[6,8,12,21] Furthermore, pre-
vious studies have shown that there is a potential for vascular 
tissue engineering in CNF material[14,20,42] and the chemistry 
allows for the addition of bioactive functional groups on to the 
fiber surface. As previously mentioned, the CNF hydrogel has 
a defined chemistry from only plant origin, which in principle 
would enable FDA approval[3] and compliance with GMP con-
ditions, opening up the possibility for clinical translation.[43] 
Due to its mechanical properties in the required range of 
0.2–1 kPa[3] and its shear-thinning characteristic, CNF hydrogel 
is suitable for bioprinting and through the addition of cellulase 
enzymes, it is also degradable.[12,22,24]
4. Conclusion
In conclusion, this study shows that the differentiation of liver 
organoids into functional hepatocyte-like cells is at least as suc-
cessful in CNF hydrogel compared to MG and sometimes supe-
rior The TEMPO-oxidized CNF hydrogel showed advantages 
with regard to the expression of hepatic genes, overall hepato-
cyte function, and organoid polarization. In combination with 
the natural biocompatibility, the mechanical properties of CNF 
hydrogels, such as the rapid self-healing and shear-thinning 
behavior, prove to provide a supportive environment for the 
differentiation of liver organoids and offer to be a good alter-
native to MG in tissue engineering and regenerative medicine. 
Further improvements might be possible through the addition 
of the degrading cellulase enzyme,[24] adding other bioactive 
moieties to the nanofibrils, producing smaller CNF microgels, 
or by further tuning of the elastic modulus of the hydrogel.[17]
5. Experimental Section
CNF Hydrogel: The CNF hydrogel was produced with the TEMPO 
method, where paper pulp (Papiertechnische Stiftung, Heidenau, 
Germany) was oxidized, then dispersed in water and homogenized 
under high pressure.[18,44,45] Sterility was achieved by autoclaving the gel 
at 121 °C for 20 min. The stock concentration of cellulose (CNF) after 
this procedure was 0.6% (w/v) (CNF 0.6) at a pH of 6. The 0.6% (w/v) 
CNF hydrogel was diluted with sterile demineralized water to 0.4% (w/v) 
(CNF 0.4) and 0.2% (w/v) (CNF 0.2).
Organoid Expansion and Differentiation: Human liver organoid cultures 
were generated from three independent, anonymized adult organ 
donors. Tissue samples (<0.5 cm3) of donor liver biopsies collected 
during liver transplantation at the Erasmus Medical Center Rotterdam 
were routinely taken to test for any liver pathology. Use of these tissues 
for research purposes was approved by the Medical Ethical Council of 
the Erasmus MC and informed consent was given by recipients (MEC-
2014-060). Biopsies were stored in ice cold organ preservation fluid 
(University of Wisconsin Solution, Bridge of Life Ltd, London, UK) 
for transportation and processed for organoid-initiation as described 
previously [8]. In short, cells were cultured in MG (Corning, New York, 
NY, USA) droplets in 24-well plates in EM for up to 13 passages. EM 
consisted of Advanced DMEM/F12 supplemented with 1% (v/v) 
penicillin-streptomycin (ThermoFisher, Waltham, MA, USA), 1% (v/v) 
GlutaMax (ThermoFisher), 10 mM HEPES (ThermoFisher), 2% (v/v) 
B27 supplement without vitamin A (Invitrogen, Carlsbad, CA, USA), 1% 
N2 supplement (Invitrogen), 10 × 10−3 m nicotinamide (Sigma-Aldrich, 
Zwijndrecht, the Netherlands), 1.25 × 10−3 m N-acetylcysteine (Sigma-
Aldrich), 10% (v/v) R-spondin-1 conditioned medium (the Rspo1-
Fc-expressing cell line was a kind gift from Calvin J. Kuo), 10 × 10−6 m 
forskolin (Sigma-Aldrich), 5 × 10−6 m A83-01 (Tocris Bioscience, Bristol, 
UK), 50 ng mL−1 EGF (Invitrogen), 25 ng mL−1 HGF (Peprotech, London, 
UK), 0.1 mg mL−1 FGF10 (Peprotech), 10 × 10−9 m recombinant human 
(Leu15)-gastrin I (Sigma-Aldrich), and 0.1 mg mL−1 Noggin (Peprotech).
To assess the possibility to expand liver organoids in CNF hydrogel, 
organoids cultured in MG (Corning) were reseeded into either 50 µL 
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fresh MG, CNF 0.4 or CNF 0.6 (n = 3 for each condition) and cultured 
with 500 µL EM medium for 7 days with medium changes on days 2 
and 4.
For the differentiation experiments, EM was supplemented with 
25 ng mL−1 BMP-7 (Peprotech) 4 days prior to organoid transfer and 
the start of differentiation. At the start of differentiation, the organoids 
were reseeded into 50 µL MG or CNF hydrogels (CNF 0.2, CNF 0.4, CNF 
0.6) and DM was added. DM consisted of EM without R-spondin-1 and 
nicotinamide but with the addition of 25 ng mL−1 BMP7 (Peprotech), 
10 × 10−6 m DAPT (γ-secretase inhibitor, Selleckchem, Houston, TX, 
USA), 100 ng mL−1 FGF19 (R&D Systems, Minneapolis, MN, USA), and 
30 × 10−6 m dexamethasone (Sigma-Aldrich). Media was refreshed on 
days 4 and 6 until the culture was terminated on day 7. In the case of 
MG, EM was added as a control.
Analyses—Hydrogel Characterization: Rheological tests to characterize 
the material (n = 1) were performed on the stock concentration of 0.6% 
(w/v) CNF hydrogel with a 1HR-3 DHR-3 rheometer in combination with 
a SST ST 20 mm 2° smart-sweep cone plate and analyzed with Texas 
Instrument TRIOS software (Texas Instruments, Dallas, TX, USA). The 
protocol for characterization of a hydrogel was applied as described 
by Zuidema et al.[27] and adopted according to Rowland et al.[26] For all 
measurements, 400 µL of CNF hydrogel was used, the gap between 
plates was set to 0.5 mm, and temperature was constant at 20 °C. The 
gel was soaked for 60 s to allow the gels to swell after compression and 
equilibrate to the temperature. Dynamic oscillatory amplitude sweep 
measurements were taken at 1 rad s−1 and oscillatory frequency sweep 
measurements were conducted at 0.5% oscillating strain. For altering 
strain experiments, the strain was altered between 1% and 500% in 
periods of 30 s and flow sweeps were conducted with 5 s equilibration 
time and 30 s averaging time. The Young’s modulus (E) was calculated 
by determining the plateau value of the frequency sweep (G′e) and with 
an assumed Poisson’s ratio (ν) of 0.5 of incompressible materials 
according to Equation (1):
2 1eE G v( )= × ′ +  (1)
Swelling of the prepared gel was measured by submerging 0.5 of 
the 0.6% (w/v) CNF hydrogel in 2 mL demineralized water and 1× PBS 
for 30 min, 1 h, and 4 h and the liquid is renewed after 2 min, 20 min, 
and then every hour (n = 3). For each timepoint, the swelling ratio is 
calculated by measuring the wet weight of the swollen gels with the 
cellulose concentrations before and after swelling.
Analyses—Morphology: The morphology of the organoids was 
followed over time for all conditions and brightfield images were taken 
at days 1 and 7 after the start of differentiation with an Olympus Color 
CCD microscope (CKX41, Tokyo, Japan), Leica DFC425C camera, 
and accompanying Leica-suite software (Wetzlar, Germany), and 
postprocessed with Image-J software (NIH, Madison, WI, USA).
Analyses—Metabolic Activity: Metabolic activity of the organoids in all 
conditions was measured on days 1, 4, 6, and 7 (days 2, 4, and 7 for 
the expansion experiment) with the Alamar Blue assay (Invitrogen) with 
n = 3 per condition. The Alamar Blue solution was diluted to 10% (v/v) 
with Advanced DMEM/F12 medium (Gibco) and incubated in three wells 
for each hydrogel condition and donor, and wells with gel but without 
organoids (n = 3 per condition) for 2 h. Fluorescence was measured at 
540−590 nm with a DxC-600 Beckman plate reader (Beckman Coulter, 
Brea, CA, USA) and the levels of the wells without organoids were 
subtracted from the read-outs for background correction. All values were 
compared to day 1, which was set to 100% of metabolic activity.
Analyses—Gene Expression: Gene expression analysis on all 
conditions (MG, CNF 0.2, CNF 0.4, CNF 0.6) and respective medium 
condition (DM, EM) were used to assess the differentiation status of 
the organoids (n = 6 per condition). The samples were lysed with 
350 µL RLT buffer (Qiagen, Hilden, Germany) containing 1% (v/v) 
2-Mercaptoethanol (Sigma-Aldrich). Isolation of mRNA was done 
according to the manufacturer’s instructions with a RNeasy micro-kit 
(Qiagen) and the total mRNA was measured with a NanoDrop ND-1000 
spectrophotometer (ThermoFisher Scientific, Breda, The Netherlands) 
at 260−280 nm. For the synthesis of complementary DNA (cDNA) from 
500 ng mRNA, the manufacturer’s protocol for the used iScript cDNA 
Synthesis Kit (Bio-Rad, Hercules, CA, USA) was applied. Quantitative 
PCR (qPCR) was performed using a Bio-Rad CFX384 Real-Time PCR 
Detection System (Bio-Rad) with 10 ng cDNA per reaction and iQ SYBR 
Green Supermix (Bio-Rad). Primers are listed in Table 1. Data were 
analyzed with Bio-Rad CFX manager software (CFX Maestro, Bio-Rad), 
relative gene expression was calculated according to the 2−ΔCT formula 
and normalized to the reference genes GAPDH and RPL19. As reference, 
samples from hepatocytes pooled from 10 donors (mixed gender, 
LiverPool Cryoplateable Hepatocytes, BioreclamationIVT, Brussels, 
Belgium) and a whole liver sample from one donor were added to the 
analysis.
Analyses—Hepatic Function: To measure the enzyme activity, the 
same samples used for metabolic activity analysis (n = 3 per condition) 
were lysed with Milli-Q water (Merck, Millipore, Burlington, MA, USA). 
Subsequently, ALAT, ASAT, Albumin, GLDH, as well as total protein, 
were measured with the clinical chemistry analyzer Beckman AU680 
(Beckman Coulter) using standard protocols. Finally, albumin values 
were corrected for total protein levels and all enzyme values were divided 
by the metabolic activity values to correct for the number of viable cells.
Analyses—Histology: Hydrogel samples from each condition 
(n = 2 per condition) were fixed with 4% paraformaldehyde and 
embedded in paraffin. For stainings, 5 µm sections were cut and 
sections were deparaffinized and rehydrated.
For immunohistochemistry, the slides were blocked in 10% (v/v) 
normal goat serum (Bio-Rad), after antigens were retrieved. Antigen 
retrieval for albumin and HNF4a staining was achieved with a 10 mM 
Tris−1 mM EDTA solution (both Sigma-Aldrich) with 0.5% Tween 
20 (Merck KGaA, Darmstadt, Germany) at pH 9.0 for 30 min at 
98 °C. For MRP2 antigen retrieval was performed with a 10 mM citrate 
buffer (Merck) at pH 6 for 30 min at 98 °C and ZO1 antigen retrieval 
was performed with 0.4% (w/v) pepsin (Dako, Santa Clara, CA, USA) 
in 0.2 N HCl (Merck) for 20 min at 37 °C. The primary antibody for 
albumin (A6684, Sigma-Aldrich), was incubated in a 1:1000 dilution; 
HNF4a (sc8987, Santa Cruz, Dallas, TX, USA) in a 1:300 dilution; MRP2 
(Mon9027, Monosan, Uden, the Netherlands) in a 1:75 dilution; and ZO1 
(40-2300, Invitrogen) in a 1:250 dilution, all incubations were performed 
overnight at 4 °C. The wash buffer for albumin, HNF4a, MRP2, and 
ZO1 was PBS + 0.1% (v/v) Tween 20. Envisioning of the antibodies was 
achieved with goat-anti-mouse/rabbit HRP (ImmunoLogic, Amsterdam, 
the Netherlands) and DAB/metal (ImmunoLogic) concentrate. As a 
counterstain hematoxylin (Dako, Glostrup, Denmark) was applied 
and slides were mounted with Vectamount (Vector Laboratories, 
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Peterborough, UK) after dehydration. Images were taken on the 
Olympus BX60 microscope (Olympus, Leiderdorp, the Netherlands) and 
processed with Image-J software (NIH, Madison, WI, USA).
PAS Staining: The PAS staining was performed by the Veterinary 
Pathology Diagnostics Centre in Utrecht according to the standardized 
procedures.
Statistical Analysis: Extreme outliers with values more than three times 
the interquartile range were identified for each outcome parameter and 
excluded from further analysis using SPSS Statistics 25 (IBM, Armonk, 
NY, USA). Statistical analysis for all data was performed with Graphpad 
Prism 8 (San Diego, CA, USA).
For the metabolic activity studies with averaged CNF hydrogel 
concentrations, a two-way ANOVA analysis was performed followed by a 
Tukey post-hoc test. For the metabolic activity study comparing different 
CNF hydrogel conditions, multiple t-tests using the Holm−Sidak method 
were executed. After careful investigation of all data, no significant 
differences between the different CNF hydrogel concentrations were found 
(see Figures S2, S3, S4, Supporting Information). Therefore, data for each 
read-out of all CNF hydrogel concentrations were averaged in further 
analysis. Data of transaminase activity and gene expression averaged over 
CNF hydrogel concentrations were log-transformed and then a one-way 
ANOVA was performed with Tukey’s post-hoc test. Data of transaminase 
activity and gene expression comparing different CNF hydrogel 
concentration were log-transformed and then a mixed-effects analysis was 
performed to account for missing values followed by Tukey’s post-hoc test. 
All transformed data were back transformed for reporting. All analyzed data 
were normally distributed and had equal variances as tested by examining 
the normal Q−Q plot of residuals and the scatter plots of residuals over 
predicted values, respectively. Differences were considered statistically 
significant for p < 0.05, and p-values were depicted in the figures, where 
asterisks represented the statistical significance (*p < 0.05, **p < 0.01 
***p < 0.001, ****p < 0.0001, ns: not significant). Furthermore, n refers to 
the sample size for each statistical analysis. Data were presented as a box 
diagram with median and 25th and 75th percentiles and whiskers from min 
to max for metabolic activity (DM conditions) data and bar graphs with 
mean and standard deviation for all other data sets.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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